Nakamura Y, Ikeda S, Furukawa T, Sumizawa T, Tani A, Akiyama S, Nagata Y
The Institute for Cancer Research and Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Sakuragaoka, Japan.
Biochem Biophys Res Commun. 1997 Jun 27;235(3):849-53. doi: 10.1006/bbrc.1997.6855.
We examined the expression of P-glycoprotein in human placentas and hydatidiform moles. Trophoblasts in all the examined placentas and moles expressed P-glycoprotein, and the size of the P-glycoprotein was smaller than that in multidrug-resistant human epidermoid carcinoma KB cells. The P-glycoprotein in the placenta and mole was photolabeled with [3H]azidopine, and [3H]vincristine was transported in an ATP-dependent manner into membrane vesicles prepared from trophoblasts that expressed P-glycoprotein. These findings indicate that P-glycoprotein expressed in trophoblasts has a drug binding site(s) and the ability to transport vincristine, suggesting that P-glycoprotein in the placenta protects the fetus from xenobiotics and confers drug resistance on moles.
我们检测了人胎盘和葡萄胎中P-糖蛋白的表达。所有检测的胎盘和葡萄胎中的滋养层细胞均表达P-糖蛋白,且其大小比多药耐药的人表皮样癌KB细胞中的小。胎盘和葡萄胎中的P-糖蛋白用[3H]叠氮平进行光标记,并且[3H]长春新碱以ATP依赖的方式转运到由表达P-糖蛋白的滋养层细胞制备的膜囊泡中。这些发现表明,滋养层细胞中表达的P-糖蛋白具有药物结合位点以及转运长春新碱的能力,提示胎盘中的P-糖蛋白可保护胎儿免受外源性物质影响,并赋予葡萄胎耐药性。